These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 36232867)

  • 1. A Pathophysiological Intersection of Diabetes and Alzheimer's Disease.
    Čater M; Hölter SM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Alzheimer's disease a type 3 diabetes? A review.
    Janoutová J; Machaczka O; Zatloukalová A; Janout V
    Cent Eur J Public Health; 2022 Sep; 30(3):139-143. PubMed ID: 36239360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Resistance and Cognitive Impairment: Evidence From Neuroimaging.
    Cui Y; Tang TY; Lu CQ; Ju S
    J Magn Reson Imaging; 2022 Dec; 56(6):1621-1649. PubMed ID: 35852470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and pathological brain ageing.
    Cholerton B; Baker LD; Craft S
    Diabet Med; 2011 Dec; 28(12):1463-75. PubMed ID: 21974744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
    J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From obesity to Alzheimer's disease through insulin resistance.
    Terzo S; Amato A; Mulè F
    J Diabetes Complications; 2021 Nov; 35(11):108026. PubMed ID: 34454830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Rodriguez-Casado A; Toledano-Díaz A; Toledano A
    Curr Alzheimer Res; 2017; 14(8):894-911. PubMed ID: 28317485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
    Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Luchsinger JA
    Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: A Focus on Insulin Resistance.
    Ezkurdia A; Ramírez MJ; Solas M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline.
    Ehtewish H; Arredouani A; El-Agnaf O
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.
    Cardoso S; Seiça R; Moreira PI
    Adv Neurobiol; 2017; 19():117-150. PubMed ID: 28933063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connecting type 2 diabetes to Alzheimer's disease.
    De Felice FG
    Expert Rev Neurother; 2013 Dec; 13(12):1297-9. PubMed ID: 24236899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.